Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardio Diagnostics Holdings (CDIO) Share-based Compensation (2023 - 2025)

Historic Share-based Compensation for Cardio Diagnostics Holdings (CDIO) over the last 3 years, with Q3 2025 value amounting to $24762.0.

  • Cardio Diagnostics Holdings' Share-based Compensation rose 947.92% to $24762.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $108567.0, marking a year-over-year decrease of 9587.32%. This contributed to the annual value of $2.6 million for FY2024, which is 10255.0% up from last year.
  • As of Q3 2025, Cardio Diagnostics Holdings' Share-based Compensation stood at $24762.0, which was up 947.92% from $30778.0 recorded in Q2 2025.
  • Cardio Diagnostics Holdings' 5-year Share-based Compensation high stood at $2.5 million for Q1 2024, and its period low was $4000.0 during Q1 2023.
  • Over the past 3 years, Cardio Diagnostics Holdings' median Share-based Compensation value was $30612.0 (recorded in 2025), while the average stood at $359690.3.
  • As far as peak fluctuations go, Cardio Diagnostics Holdings' Share-based Compensation surged by 6288510.0% in 2024, and later crashed by 9878.5% in 2025.
  • Over the past 3 years, Cardio Diagnostics Holdings' Share-based Compensation (Quarter) stood at $62000.0 in 2023, then crashed by 63.85% to $22415.0 in 2024, then increased by 10.47% to $24762.0 in 2025.
  • Its Share-based Compensation was $24762.0 in Q3 2025, compared to $30778.0 in Q2 2025 and $30612.0 in Q1 2025.